Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 21 Mar 2025

A viral infection prediction model for patients with r/r B-cell malignancies after CAR-T therapy: a retrospective analysis

in Hematologic Malignancies

Shujing Guo
Jile Liu
Bing Wang
Xiaomei Zhang
Yifan Zhao
Jianmei Xu
Xinping Cao
Mohan Zhao
Xia Xiao
Mingfeng Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1549809

603 views

Correction

Published on 21 Mar 2025

Corrigendum: Efficacy and survival outcome of allogeneic stem-cell transplantation in multiple myeloma: meta-analysis in the recent 10 years

in Hematologic Malignancies

Si Yu Lin
Ke Jie Lu
Xiao Na Zheng
Jian Hou
Ting Ting Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1559194

432 views

Original Research

Published on 20 Mar 2025

Development of a mitochondria-related gene signature for prognostic assessment in diffuse large B cell lymphoma

in Hematologic Malignancies

Fujue Wang
Yu Gao
Yue Chen
Pian Li
Yao Zeng
Yingying Chen
Yangcui Yin
Yongqian Jia
Yongsheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1542829

678 views

Editorial

Published on 19 Mar 2025

Editorial: Allogenic hematopoietic cell transplant in hematological malignancies: controversies and perspective

in Hematologic Malignancies

Salvatore Leotta
Sabrina Giammarco
Jacopo Mariotti

Frontiers in Oncology

doi 10.3389/fonc.2025.1582751

314 views

Systematic Review

Published on 18 Mar 2025

Prognostic and clinicopathological value of the controlling nutritional status score in patients with multiple myeloma: a meta-analysis

in Hematologic Malignancies

Yin Jin
Wenfei Gu

Frontiers in Oncology

doi 10.3389/fonc.2025.1517223

560 views

Case Report

Published on 14 Mar 2025

Next-generation sequencing guides diagnosis and treatment in a complex presentation of ALK-positive anaplastic large-cell lymphoma: a case report

in Hematologic Malignancies

Tejasvini Vaid
Thomas S. Gunning
Rachel Cohen
Alexandra Della Pia
Jason Voss
Melinda Weber
Andrew L. Pecora
Lori A. Leslie
Tatyana Feldman
Andre H. Goy

Frontiers in Oncology

doi 10.3389/fonc.2025.1502782

1,141 views

Original Research

Published on 13 Mar 2025

The immune cell dynamics in the peripheral blood of cHL patients receiving anti-PD1 treatment

in Hematologic Malignancies

Vanessa Cristaldi
Lodovico Terzi di Bergamo
Lucrezia Patruno
Marinos Kallikourdis
Giada Andrea Cassanmagnago
Francesco Corrado
Eleonora Calabretta
Adalgisa Condoluci
Martina di Trani
Daoud Rahal

Frontiers in Oncology

doi 10.3389/fonc.2025.1518107

803 views

Original Research

Published on 12 Mar 2025

Operational procedure sharing pathway in veno-occlusive disease: a Delphi consensus-based recommendations

in Hematologic Malignancies

Francesca Bonifazi
Federico Ravaioli
Anna Paola Iori
Giuseppe Milone
Attilio Olivieri
Arcangelo Prete
Domenico Russo
Stella Santarone
Simona Sica
Marco Zecca

Frontiers in Oncology

doi 10.3389/fonc.2025.1498782

621 views

Systematic Review

Published on 12 Mar 2025

Clinical outcomes associated with anti-CD38-based retreatment in relapsed/refractory multiple myeloma: a systematic literature review

in Hematologic Malignancies

Francesca Gay
Elena Zamagni
Craig Emmitt Cole
Christof Scheid
Malin Hultcrantz
Justyna Chorazy
Ike Iheanacho
Anuja Pandey
Jacopo Bitetti
Natalie Boytsov

Frontiers in Oncology

doi 10.3389/fonc.2025.1550644

1,617 views

Original Research

Published on 07 Mar 2025

Anemia and blood transfusions in myelofibrosis: economic and organizational impact on Italian patients, caregivers and hospitals

in Hematologic Malignancies

Francesca Palandri
Alessandro Inzoli
Antonella Barone
Daniela Dordoni
Elisa Formenti
Giorgio Corradini D’Elia
Victoria Lucia Rabsiun Aramburu
Giuseppe Alberto Palumbo
Massimo Breccia

Frontiers in Oncology

doi 10.3389/fonc.2025.1549023

1,314 views

Original Research

Published on 06 Mar 2025

Associations of ANGPT2 expression and its variants (rs1868554 and rs7825407) with multiple myeloma risk and outcome

in Hematologic Malignancies

Sylwia Popek-Marciniec
Wojciech Styk
Sylwia Chocholska
Aneta Szudy-Szczyrek
Katarzyna Sidor
Grazyna Swiderska-Kolacz
Marek Hus
Joanna Czerwik-Marcinkowska
Szymon Zmorzynski

Frontiers in Oncology

doi 10.3389/fonc.2025.1468373

608 views

Original Research

Accepted on 05 Mar 2025

Complex causal association between genetically predicted 731 immunocyte phenotype and leukaemia: A bidirectional Two-sample mendelian randomization analysis

in Hematologic Malignancies

Chenyang Fan
Pengying Yuan
Weifeng Zhang
Haijing Chen
Xinli Zhou
Yucheng Zhang
Gengda Zhu
Chengyulong Zheng
Lixiang Yan
Zhexin Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1435783

124 views

Review

Published on 05 Mar 2025

Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions

in Hematologic Malignancies

Huiquan Wang
Jiafeng Zhang
Hefei Ren
Lei Chen
Jigang Ren
Chang Liu
Hongkun Wu
Lin Zhou

Frontiers in Oncology

doi 10.3389/fonc.2025.1531928

881 views

Review

Published on 03 Mar 2025

Advancing the understanding and management of angioimmunoblastic T-cell lymphoma: insights into its pathogenesis, clinical features, and emerging therapeutic strategies

in Hematologic Malignancies

Yurou Xing
Junmeng Huang
Yi Zhang
Yongsheng Wang
Shaochong Qi

Frontiers in Oncology

doi 10.3389/fonc.2025.1479179

1,201 views
1 citation

Original Research

Published on 03 Mar 2025

Retrospective study of chidamide-containing regimens as maintenance therapy among T- and NK-cell lymphoma patients

in Hematologic Malignancies

Tao Hai
Wanchun Wu
Kexin Ren
Na Li
Liqun Zou

Frontiers in Oncology

doi 10.3389/fonc.2025.1507418

478 views

Original Research

Published on 28 Feb 2025

Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life

in Hematologic Malignancies

Julia Nenonen
Anna H. Winther
Pontus Jonsson
Lina U. Ivert
Hanna Brauner

Frontiers in Oncology

doi 10.3389/fonc.2025.1524353

615 views